These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21212695)

  • 1. Does antenatal exposure to magnesium sulphate compromise the neonatal gut? Unpicking the evidence.
    Warrick C; Nicholl R
    Neonatology; 2011; 100(1):50-1. PubMed ID: 21212695
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of maternal magnesium sulfate administration on intestinal blood flow velocity in preterm neonates.
    Havranek T; Ashmeade TL; Afanador M; Carver JD
    Neonatology; 2011; 100(1):44-9. PubMed ID: 21212694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antenatal magnesium sulfate therapy on cerebral and systemic hemodynamics in preterm newborns.
    Shokry M; Elsedfy GO; Bassiouny MM; Anmin M; Abozid H
    Acta Obstet Gynecol Scand; 2010 Jun; 89(6):801-6. PubMed ID: 20504082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term maternal intravenous magnesium sulfate therapy on neonatal calcium metabolism and bone mineral content.
    Schanler RJ; Smith LG; Burns PA
    Gynecol Obstet Invest; 1997; 43(4):236-41. PubMed ID: 9194621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the pharmacological use of intravenous magnesium before preterm cerebroprotective or deleterious for premature infants? Possible importance of the use of magnesium sulphate.
    Durlach J; Bac P; Bara M; Guiet-Bara A
    Magnes Res; 1998 Dec; 11(4):323-5. PubMed ID: 9884990
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of antenatal magnesium exposure on intestinal blood flow and outcome in preterm neonates.
    Gursoy T; Imamoglu EY; Ovali F; Karatekin G
    Am J Perinatol; 2015 Sep; 32(11):1064-9. PubMed ID: 25825964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium sulphate for the prevention of cerebral palsy in Australia and New Zealand.
    Bain E; Goodchild L; Lontis R; McIntyre S; Ashwood P; Bubner T; Middleton P; Crowther C
    Aust Nurs J; 2013 Jul; 21(1):34-7. PubMed ID: 23930314
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neuroprotection for preterm infants with antenatal magnesium sulphate].
    Marret S; Ancel PY
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1418-1433. PubMed ID: 28166926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal magnesium treatment and neonatal illness severity as measured by the Score for Neonatal Acute Physiology (SNAP).
    Deering SH; Stagg AR; Spong CY; Abubakar K; Pezzullo JC; Ghidini A
    J Matern Fetal Neonatal Med; 2005 Feb; 17(2):151-5. PubMed ID: 16076625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antenatal magnesium sulfate and neurodevelopmental outcome of preterm infants born to preeclamptic mothers.
    Bozkurt O; Eras Z; Canpolat FE; Oguz SS; Uras N; Dilmen U
    J Matern Fetal Neonatal Med; 2016; 29(7):1101-4. PubMed ID: 25893546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antenatal magnesium sulphate neuroprotection in the preterm infant.
    Marret S; Doyle LW; Crowther CA; Middleton P
    Semin Fetal Neonatal Med; 2007 Aug; 12(4):311-7. PubMed ID: 17513184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does magnesium exposure affect neonatal resuscitation?
    Drassinower D; Friedman AM; Levin H; Običan SG; Gyamfi-Bannerman C
    Am J Obstet Gynecol; 2015 Sep; 213(3):424.e1-5. PubMed ID: 26026919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antenatal magnesium sulphate exposure is associated with prolonged parathyroid hormone suppression in preterm neonates.
    Rantonen T; Kääpä P; Jalonen J; Ekblad U; Peltola O; Välimäki I; Kero P
    Acta Paediatr; 2001 Mar; 90(3):278-81. PubMed ID: 11332167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of MgSO-4 on fetus, newborn infant and uterine activity].
    Presl J
    Cesk Gynekol; 1972 Mar; 37(2):112-3. PubMed ID: 5023965
    [No Abstract]   [Full Text] [Related]  

  • 15. Magnesium as a Neuroprotective Agent: A Review of Its Use in the Fetus, Term Infant with Neonatal Encephalopathy, and the Adult Stroke Patient.
    Lingam I; Robertson NJ
    Dev Neurosci; 2018; 40(1):1-12. PubMed ID: 29408814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium sulphate and perinatal mortality and morbidity in very-low-birthweight infants born between 24 and 32 weeks of gestation in Japan.
    Ohhashi M; Yoshitomi T; Sumiyoshi K; Kawagoe Y; Satoh S; Sameshima H; Ikenoue T
    Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():140-5. PubMed ID: 27131232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of common treatments given in the perinatal period on the developing brain.
    Favrais G; Tourneux P; Lopez E; Durrmeyer X; Gascoin G; Ramful D; Zana-Taieb E; Baud O
    Neonatology; 2014; 106(3):163-72. PubMed ID: 25012048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does exposure to magnesium sulfate in utero decrease the risk of necrotizing enterocolitis in premature infants?
    Ghidini A; Espada RA; Spong CY
    Acta Obstet Gynecol Scand; 2001 Feb; 80(2):126-9. PubMed ID: 11167206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal magnesium exposure and neonatal demise.
    Farkouh LJ; Thorp JA; Jones PG; Clark RH; Knox GE
    Am J Obstet Gynecol; 2001 Oct; 185(4):869-72. PubMed ID: 11641668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antenatal Exposure to Magnesium Sulfate Is Associated with Reduced Cerebellar Hemorrhage in Preterm Newborns.
    Gano D; Ho ML; Partridge JC; Glass HC; Xu D; Barkovich AJ; Ferriero DM
    J Pediatr; 2016 Nov; 178():68-74. PubMed ID: 27453378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.